Q3 2014 Holdings
Filed 2014-11-14 | 15 holdings | $257.1K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2014-12-09) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Medivation, Inc. | Com | 58501N101 | $221.9K | 2,244,519 | 86.3% |
| Ampio Pharmaceuticals Inc. | Com | 03209T109 | $12.0K | 3,370,822 | 4.7% |
| Alcobra Ltd | SHS | M2239P109 | $10.6K | 687,000 | 4.1% |
| Keryx Biopharmaceuticals Inc. | Com | 492515101 | $2.8K | 200,000 | 1.1% |
| Bio Blast Pharma LtdA | SHS | M20156101 | $2.5K | 338,110 | 1.0% |
| Synthetic Biologics Inc. | COM | 87164U102 | $2.4K | 1,360,000 | 0.9% |
| Newlink Genetics Corp | Com | 651511107 | $1.7K | 77,437 | 0.6% |
| Inovio Pharmaceuticals Inc. | COM NEW | 45773H201 | $1.0K | 102,088 | 0.4% |
| Advaxis Inc. | COM NEW | 007624208 | $756 | 225,000 | 0.3% |
| Galmed Pharmaceuticals Ltd(GLMD) | SHS | M47238106 | $559 | 65,000 | 0.2% |
| Northwest Biotherapeutics Inc(NWBO) | COM PAR $0.001 | 66737P600 | $337 | 67,035 | 0.1% |
| Nephrogenex Inc | COMM | 640667101 | $234 | 50,000 | 0.1% |
| Provectus Biopharmaceuticals(PVCT) | COM | 74373P108 | $204 | 200,000 | 0.1% |
| Advaxis Inc. | W EXP 07/15/201 | 007624117 | $162 | 112,500 | 0.1% |
| Cellectar Biosciences Inc | COM NEW | 15117F203 | $33 | 14,634 | 0.0% |